EGF THERAMED HEALTH CORP.

Research EGF THERAMED HEALTH CORP. (AUH) on Bullrun: market cap EUR 197.48K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 197.48K.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CAD 0-CAD 3.09M-CAD 94.70Kn/an/aCAD 10.25KCAD 1.63M-CAD 4.64M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24EUR 197.48Kn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About EGF THERAMED HEALTH CORP.

EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company also explores other medical areas, including weight loss, skin care, and heart disease. EGF Theramed Health Corp. is headquartered in Vancouver, Canada.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is EGF THERAMED HEALTH CORP.'s market cap?

EGF THERAMED HEALTH CORP.'s market capitalization is EUR 197.48K.

What does EGF THERAMED HEALTH CORP. do?

EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company also explores other medical areas, including weight loss, skin care, and heart disease. EGF Theramed Health Corp. is headquartered in Vancouver, Canada.